Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the September 3, 2014, Federal Register, FDA issued a final order classifying early growth response 1 ("EGR1") gene fluorescence in-situ hybridization ("FISH") test system for specimen characterization into class II (special controls).
United StatesFood, Drugs, Healthcare, Life Sciences
In the September 3, 2014, Federal Register,
FDA issued a final order classifying early growth response 1
("EGR1") gene fluorescence in-situ hybridization
("FISH") test system for specimen characterization into
class II (special controls). Effective October 3,
2014.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
